Having trouble viewing this email? View in your browser.
ESCMID Logo

29 October 2019
WEEKLY NEWS

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,
ESCMID Executive Office.

 

ECCMID 2020 is approaching: don’t miss the opportunity to enjoy Prof. Arturo Casadevall’s Keynote Lecture. Register now!

It is an honour for ESCMID to have Prof. Arturo Casadevall, chair of the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health (Baltimore, USA), as a keynote speaker at ECCMID 2020! The title of his keynote lecture will be “On virulence”.

Visit the ECCMID 2020 website to find out about our outstanding keynote speakers and to take advantage of early registration discounts!

› Read more

ESCMID Postgraduate Education Courses – Grants Available!

Did you know that all ESCMID postgraduate courses and technical workshops are supported by attendance grants for ESCMID members?

All courses open for registration are also open for grant applications!

Find out more about the upcoming 2020 courses and workshops on the
courses website!

› Read more

European Commission open consultations

Consultations for European Partnerships under Horizon Europe is open here. Within these partnerships there are two that concern directly Health activities, and are relevant for infectious diseases:

• The EU-Africa Global Health Partnership, to help to inform the further development of the current EDCTP partnership.

• The European Partnership for Innovative Health, to help to inform the further development of the current IMI partnership.

The consultation is open until the 6th of November 2019.

› Read more
 

ESCMID Offshore Postgraduate Education Course: Tuberculosis and Mycobacterial infections – An update in Singapore

The ESCMID Postgraduate Educational Course on TB and Mycobacterial Infections was successfully held from 26 - 28th September 2019 in Singapore, jointly organised with the Society of Infectious Disease (Singapore).

Topics ranged from Epidemiology, Pathophysiology, Diagnostics, Care delivery, Basic research, Case-based discussions, to non-tuberculous mycobacteria including leprosy. There were excellent talks given by the 21 local and the overseas faculty in addition to poster presentations.

Find out more, access the presentations on the E-Library and read the full report on the ESGMYC website.

› Read more
 

CMI Highlight: Evaluation of the BD Phoenix™ CPO detect test for detection of carbapenemase producers

A. Croxatto et al, study aimed at (i) determining the performance of the Phoenix™ CPO (Carbapenemase-Producing Organisms) tests and (ii) assessing its added value in routine diagnostic workflows.

Becton-Dickinson recently developed the Phoenix™ CPO (Carbapenemase-Producing Organisms) Detect Test, a growth-based test embedded in Gram-negative (GN) panels for detection and confirmation of class A, B and D carbapenemases.
The performance of the BD Phoenix™ CPO test was analyzed retrospectively on a collection of 185 molecularly-characterized strains including 92 CPO and prospectively on 135 and 160 routine isolates with and without CPO suspicion, respectively.

A. Croxatto et al, concluded that the CPO test is reliable for the detection of CPO with a high sensitivity. However, the relatively low specificity required the use of additional confirmatory methods. The carbapenemase classification accuracy is robust to provide preliminary results before molecular characterization. Finally, the implementation of the test in routine workflows allowed a significant reduction of TAT, HOT and cost compared to the conventional approach.

› Read more
 

Guidance Reminder: New deadline for submission of proposals for ESCMID guidelines projects 2019

Due to several requests received from ESCMID members, the deadline of the first ESCMID call ESCMID call for clinical practice guidelines 2019 has been postponed until Friday, 15th of November.

The objective of this call is to invite interested parties to propose to undertake the development of full clinical practice guidelines in one of the priority topics, as listed above. They engage in following the best recognized standards for the production of clinical practice guidelines, from the identification of objectives and health questions, search and selection of relevant evidence, to the formulation of recommendations.

The selected topics are:

1) Antimicrobial stewardship
2) Diagnosis and management of influenza
3) Surgical prophylaxis and infection control means, in patients colonised by MDR pathogens before surgery
4) Diagnostic and treatment of non-hospitalized Community Acquired Pneumonia

For more information, please visit our website

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.